Literature DB >> 17676203

Complications of chemoembolization for hepatic neoplasms.

Hongxiu Dai1, Hui Ding, Faquan Liu, Zhenjiu Yao, Lina Li, Chuang Li, Yiqing Tan, Jun Wang.   

Abstract

OBJECTIVE: To present a safe and effective approach to chemoembolization for hepatic neoplasms, and to discuss the complications of chemoembolization and ways of avoiding them.
METHODS: The techniques and experience described herein are based on clinical practice at Yichang Central People's Hospital, Yichang, Hubei, China, where over 200 chemoembolization procedures are performed yearly, and on the results of an intensive review of 1054 chemoembolization procedures performed between July 1997 and December 2005.
RESULTS: There were complications as follow: 5 cases with celiac artery branch embolization, gastric uptake in 4, 6 with gallbladder uptake and infarction, splenic uptake and infarction in 8, liver infarction and abscess formation in 3, and hepatorenal syndrome in 4, liver rupture in 2, lung uptake in 6, and spinal cord injury in 2 cases.
CONCLUSION: There are numerous potential errors and complications associated with chemoembolization for unresectable liver tumors. A good understanding of the congenital and acquired variations of arterial anatomy that may be seen supplying the liver is required.

Entities:  

Mesh:

Year:  2007        PMID: 17676203

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

1.  Acute lung injury following transcatheter hepatic arterial chemoembolization of doxorubicin-loaded LC beads in a patient with hepatocellular carcinoma.

Authors:  Ihsan Khan; Viswanath Vasudevan; Sasikanath Nallagatla; Farhad Arjomand; Rana Ali
Journal:  Lung India       Date:  2012-04

2.  Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma.

Authors:  Sang Jung Park; Chang Ha Kim; Jin Dong Kim; Soon Ho Um; Sun Young Yim; Min Ho Seo; Dae In Lee; Jun Hyuk Kang; Bora Keum; Yong Sik Kim
Journal:  Clin Mol Hepatol       Date:  2012-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.